[Ip-health] Invitation to a EU Researchers Speak Out on Open Access - Wednesday, October 10th at 13h00 in A1-E201, European Parliament, Brussels
tessel at haieurope.org
Wed Oct 3 08:17:24 PDT 2012
Date: Wednesday, 10th October
Time: 13h00 - 14h30
Room: A1-E201, European Parliament, Brussels
(sandwiches & drinks will be served before the event)
Sponsored by MEP Ioannis A. Tsoukalas (EPP), MEP Luigi Berlinguer (S&D)
and MEP Philippe Lamberts (Greens/EFA) and organized with support from
TACD & HAI Europe
Why Europe's researchers and academics want a clear open access policy
in Horizon 2020
In the next few months the European Parliament will decide its position
on open access scientific publishing in Horizon 2020. A number of the
key issues at stake are the present barriers to access to knowledge
generated with EU funding, the high cost European public institutions
pay for peer-reviewed scientific journals and how to best promote
academic excellence and innovation with public funding.
* How academic publishing is changing in the digital era and what
the benefits and difficulties of open access scientific publishing
* What a clear EU open access policy in Horizon 2020 would mean
for academic excellence, innovation and for citizens in general.
* Issues to be considered: dissemination, effectiveness of public
financing, transparency, academic freedom, peer review, research
excellence and the financing of publishing costs.
* Does open access to publication and data pose affect the
management intellectual property rights?
* What is the difference between open access for publications and
open access for data?
* What are the benefits of Open Access to scientific data policies
for researchers and for public interest? What kind of data are we
* What legal language and what investments are needed in Horizon
2020 to assure open access?
13h00: Introduction by MEP Philippe Lamberts
Topic 1 - Open Access to publications
* Prof. Dr. Marie Farge (France) Research Director at the Centre
National de la Recherche Scientique (CNRS), member of the Academy of
Europe. One of the promoters of "The Cost of Knowledge" initiative that
has been supported by thousands of European researchers. She received
several including from Cray Research, American Physics Society and the
French Academy of Sciences.
* Dr. Alma Swan (UK) Consultant and advocate in the field of
scholarly communication for SPARC (Scholarly publishing and Academic
Resources Coalition), research biologist, member of governing board of
Euroscience, fellow of Society and Biology (UK) and former editor of
Questions and open debate with attendants
Topic 2 - Open Access to research data
* Dr. Elena Giglia (Italy) Open Access Projects leader at the
University of Turin; member of the Open Access Working Group at CRUI
(Conference of Italian Universities Rectors); member of the Editorial
Board of "JLIS - Italian Journal of Library and Information Science"
* Dr. Christoph Bruch (Germany) Senior advisor for Helmholtz Open
Access Coordination Office. Appointed 'lead moderator' of "Preservation
of Scientific Data" for the post-summit process of the World Summit on
the Information Society. Previously at Max Planck Society and Free
Questions and open debate with attendants
14.20: Conclusions by MEP Ioannis A. Tsoukalas and MEP Luigi Berlinguer
Please register by sending an email before October the 8th to
laurarossy at hotmail.com
Note - to get access badge to the European Parliament, please, include
the following information: full name, date of birth, nationality, type
of ID (passport, ID, driving license) and ID number. In case of any
special food requirements, please, mention it in the registration mail.
Project Officer - Trade, Innovation & Access to Medicines
Health Action International (HAI) Europe
Overtoom 60 II, 1054 HK Amsterdam
t. +31 20 683 3684
f. +31 20 685 5002
e. Tessel at haieurope.org <mailto:Tessel at haieurope.org>
w. www.haieurope.org <http://www.haieurope.org/>
Follow HAI Europe on Twitter <https://twitter.com/#!/HAIEurope> or
Health Action International (HAI) is an independent, global network
working to increase access to essential medicines and improve their
rational use through research excellence and evidence-based advocacy.
Important Email Information:
The information contained in this email is confidential and may be
legally privileged. It is intended solely for the addressee and is for
the exclusive use of the intended recipient(s). If you are not the
intended recipient(s), please note that any form of disclosure,
distribution, copying or use of this communication or the information in
it or in any attachments is strictly prohibited and may be unlawful. If
you are not the intended addressee, please contact the sender and
dispose of this e-mail immediately. Any opinions expressed are those of
the author, not of HAI.
More information about the Ip-health